IN2014MN01706A - - Google Patents
Info
- Publication number
- IN2014MN01706A IN2014MN01706A IN1706MUN2014A IN2014MN01706A IN 2014MN01706 A IN2014MN01706 A IN 2014MN01706A IN 1706MUN2014 A IN1706MUN2014 A IN 1706MUN2014A IN 2014MN01706 A IN2014MN01706 A IN 2014MN01706A
- Authority
- IN
- India
- Prior art keywords
- bitter taste
- active ingredient
- fast dissolving
- film composition
- dissolving film
- Prior art date
Links
- 235000019658 bitter taste Nutrition 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 abstract 2
- 230000000873 masking effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960003310 sildenafil Drugs 0.000 abstract 1
- 239000006068 taste-masking agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020120020316A KR101328350B1 (ko) | 2012-02-28 | 2012-02-28 | 실데나필 또는 이의 약제학적으로 허용되는 염을 유효성분으로 함유하는 고미가 은폐된 약제학적 조성물 |
| KR1020120117233A KR101440808B1 (ko) | 2012-10-22 | 2012-10-22 | 실데나필 또는 이의 약제학적으로 허용되는 염을 고함량으로 포함하는 속용필름 |
| PCT/KR2013/001679 WO2013129889A2 (ko) | 2012-02-28 | 2013-02-28 | 실데나필을 유효성분으로 함유하며 고미가 은폐된 고함량 속용필름 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01706A true IN2014MN01706A (en, 2012) | 2015-05-29 |
Family
ID=49083410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1706MUN2014 IN2014MN01706A (en, 2012) | 2012-02-28 | 2013-02-28 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10092651B2 (en, 2012) |
| EP (1) | EP2821066B1 (en, 2012) |
| JP (1) | JP5941558B2 (en, 2012) |
| CN (1) | CN104168895B (en, 2012) |
| CA (1) | CA2864322C (en, 2012) |
| IN (1) | IN2014MN01706A (en, 2012) |
| WO (1) | WO2013129889A2 (en, 2012) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989661B (zh) * | 2014-05-26 | 2016-04-20 | 苏州大学 | 西地那非口腔速溶膜剂及其制备方法 |
| KR101538985B1 (ko) * | 2014-09-02 | 2015-07-24 | 주식회사 서울제약 | 타다라필 구강붕해필름 및 이의 제조방법 |
| KR20240036586A (ko) * | 2014-12-09 | 2024-03-20 | 어퀘스티브 테라퓨틱스, 인크. | 선형 다당류-기반 필름 생성물 |
| CN104586820B (zh) * | 2015-01-13 | 2021-04-09 | 齐鲁制药有限公司 | 具有高载药量的西地那非口腔速溶薄膜组合物 |
| CN104546807B (zh) * | 2015-01-21 | 2020-09-01 | 齐鲁制药有限公司 | 奥氮平口腔速溶膜剂 |
| BR112017017428A2 (pt) | 2015-02-25 | 2018-04-03 | Eisai R&D Management Co., Ltd. | ?método para supressão do amargor de derivado de quinolina? |
| RU2718048C2 (ru) | 2015-08-20 | 2020-03-30 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Противоопухолевое терапевтическое средство |
| EP3463317A4 (en) * | 2016-06-07 | 2020-01-08 | Aridis Pharmaceuticals, Inc. | PROCESS FOR THE PREPARATION OF FAST-DISSOLVING THIN FILMS CONTAINING A BIOLOGICALLY ACTIVE SUBSTANCE WITH IMPROVED THERMAL STABILITY |
| AU2018219637B2 (en) | 2017-02-08 | 2023-07-13 | Eisai R&D Management Co., Ltd. | Tumor-treating pharmaceutical composition |
| US11096892B2 (en) * | 2017-03-13 | 2021-08-24 | Nano And Advanced Materials Institute Limited | High loading and fast disintegration film for fast drug absorption |
| CN106860404A (zh) * | 2017-04-13 | 2017-06-20 | 中国药科大学 | 一种枸橼酸西地那非掩味树脂复合物及其应用 |
| US20200197384A1 (en) | 2017-05-16 | 2020-06-25 | Eisai R&D Management Co., Ltd. | Treatment of hepatocellular carcinoma |
| CN109717282A (zh) * | 2017-10-30 | 2019-05-07 | 上海冠生园食品有限公司 | 一种富含花青素的糖果及其制备方法 |
| WO2019161322A1 (en) * | 2018-02-19 | 2019-08-22 | Monell Chemical Senses Center | Compositions and methods of ameliorating pharmaceutical aversiveness with salts |
| CN109010324B (zh) * | 2018-08-30 | 2021-07-02 | 南京康川济医药科技有限公司 | 一种西地那非口溶膜剂及其制备方法 |
| CN111466564A (zh) * | 2019-01-24 | 2020-07-31 | 甄崇礼 | 含有天然活性多糖的口腔速溶膜剂及其制备方法 |
| CN110128429A (zh) * | 2019-04-30 | 2019-08-16 | 孙常全 | 一种西地那非-安赛蜜盐型及其制备方法和用途 |
| US20220249466A1 (en) * | 2019-09-04 | 2022-08-11 | Seasons Biotechnology (Taizhou) Co., Ltd. | Coated granule, solid dispersion, and preparation containing vortioxetine hydrobromide for oral taste masking |
| US11179331B1 (en) | 2020-04-21 | 2021-11-23 | Cure Pharmaceutcai Holding Corp | Oral soluble film containing sildenafil citrate |
| GR20200100430A (el) * | 2020-06-01 | 2022-01-13 | Κυριακος Ηλια Κυπραιος | Ταχεως διαλυομενες στοματικες ταινιες για τη χορηγηση δια της στοματικης οδου φαρμακων και λοιπων βιοδραστικων ουσιων σε ανθρωπους |
| US20240065303A1 (en) * | 2020-12-22 | 2024-02-29 | Solugen, Inc. | Bitter masking agent |
| CN115252587A (zh) * | 2022-08-19 | 2022-11-01 | 南京泛太化工医药研究所 | 一种口腔速溶膜及其制备方法 |
| CN116270553B (zh) * | 2023-02-01 | 2024-05-07 | 北京悦康科创医药科技股份有限公司 | 一种爱地那非口溶膜剂及其制备方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US652024A (en) | 1898-12-08 | 1900-06-19 | James Gray | Valve mechanism for automatic water-heaters. |
| TW271400B (en, 2012) * | 1992-07-30 | 1996-03-01 | Pfizer | |
| GB9311920D0 (en) | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
| GB9401090D0 (en) | 1994-01-21 | 1994-03-16 | Glaxo Lab Sa | Chemical compounds |
| US5605889A (en) | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
| IL135462A0 (en) | 1997-11-12 | 2001-05-20 | Bayer Ag | 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| KR100353014B1 (ko) | 1998-11-11 | 2002-09-18 | 동아제약 주식회사 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물 |
| US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
| CA2417736A1 (en) * | 2000-07-19 | 2002-01-24 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
| DE10207394B4 (de) | 2002-02-21 | 2007-03-29 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte oblatenförmige Arzneizubereitung |
| GB0219516D0 (en) * | 2002-08-21 | 2002-10-02 | Phoqus Ltd | Fast dissolving and taste masked oral dosage form comprising sildenafil |
| KR20060031552A (ko) | 2004-10-08 | 2006-04-12 | 박영국 | 취수선을 이용한 해양 심층수 취수 방법 |
| US20070092553A1 (en) | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
| WO2007059591A1 (en) * | 2005-11-28 | 2007-05-31 | Imaginot Pty Ltd | Oral therapeutic compound delivery system |
| MX2008011823A (es) * | 2006-03-16 | 2008-10-31 | Novartis Ag | Forma de dosificacion solida que contiene un agente activo de sabor encubierto. |
| KR101304343B1 (ko) | 2006-04-06 | 2013-09-11 | 한미사이언스 주식회사 | Ｐｄｅ-5 억제제의 경구용 속용제형 |
| MX2009003372A (es) * | 2006-10-02 | 2009-09-24 | Labtec Gmbh | Formas de dosificacion de pelicula no mucoadhesiva. |
| CA2675356A1 (en) | 2007-01-12 | 2008-07-24 | Monosol Rx, Llc | High dose film compositions and methods of preparation |
| US20080220029A1 (en) | 2007-03-05 | 2008-09-11 | Charlene Ng | Fast-dissolving/disintegrating film preparation having high proportion of active |
| US20090047330A1 (en) * | 2007-08-17 | 2009-02-19 | Ramesh Bangalore | Oral fast dissolving films for erectile dysfunction bioactive agents |
| US20100297232A1 (en) * | 2009-05-19 | 2010-11-25 | Monosol Rx, Llc | Ondansetron film compositions |
| KR101074271B1 (ko) * | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
| DE102010049708A1 (de) * | 2010-10-28 | 2012-05-03 | Hexal Ag | Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe |
| EA201500604A1 (ru) | 2011-02-11 | 2015-09-30 | СиТиСи БАЙО, ИНК. | Пленочная лекарственная форма, содержащая свободное основание силденафила, и способ ее получения |
| KR101188594B1 (ko) | 2011-12-06 | 2012-10-08 | (주)씨엘팜 | 쓴맛이 차단된 실데나필 시트르산의 구강내 속붕해 필름제형 |
-
2013
- 2013-02-28 IN IN1706MUN2014 patent/IN2014MN01706A/en unknown
- 2013-02-28 WO PCT/KR2013/001679 patent/WO2013129889A2/ko active Application Filing
- 2013-02-28 JP JP2014554675A patent/JP5941558B2/ja active Active
- 2013-02-28 EP EP13755861.5A patent/EP2821066B1/en active Active
- 2013-02-28 US US14/379,989 patent/US10092651B2/en active Active
- 2013-02-28 CA CA2864322A patent/CA2864322C/en active Active
- 2013-02-28 CN CN201380010759.1A patent/CN104168895B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015504916A (ja) | 2015-02-16 |
| WO2013129889A9 (ko) | 2014-10-16 |
| EP2821066A4 (en) | 2015-10-21 |
| WO2013129889A3 (ko) | 2013-10-24 |
| WO2013129889A2 (ko) | 2013-09-06 |
| EP2821066A2 (en) | 2015-01-07 |
| CN104168895B (zh) | 2020-02-21 |
| CA2864322C (en) | 2016-08-09 |
| US20150025084A1 (en) | 2015-01-22 |
| JP5941558B2 (ja) | 2016-06-29 |
| CN104168895A (zh) | 2014-11-26 |
| CA2864322A1 (en) | 2013-09-06 |
| US10092651B2 (en) | 2018-10-09 |
| EP2821066B1 (en) | 2018-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01706A (en, 2012) | ||
| MX391180B (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo | |
| MX2019007956A (es) | Liberacion autorregulada de ingrediente farmaceutico activo. | |
| SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
| IN2014MN01755A (en, 2012) | ||
| MX2015010971A (es) | Derivado novedoso de pirazol. | |
| MY197785A (en) | Combinations of lsd1 inhibitors for the treatment of hematological malignancies | |
| EA201690102A1 (ru) | Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе | |
| NZ631100A (en) | Soft chewable pharmaceutical products | |
| MY180145A (en) | Cenicriviroc compositions and methods of making and using the same | |
| NZ720328A (en) | Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease | |
| IN2013MU03583A (en, 2012) | ||
| HK1223304A1 (zh) | 包含二甲双胍和二氢槲皮素的药物组合及其用於治疗癌症的用途 | |
| MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| PH12014501545A1 (en) | Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof | |
| PH12013500784A1 (en) | Pharmaceutical compositions comprising nano size droplets of skin whitening agents | |
| EP3162804A8 (en) | New benzodiazepine derivative and use thereof | |
| PH12015500653B1 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
| MX2023012198A (es) | Composiciones de amantadina, preparaciones de estas y metodos de uso. | |
| HK1214519A1 (zh) | 雙用途硫酸鹽口服藥物組合物片劑及其使用方法 | |
| WO2014122460A3 (en) | Pemetrexed complexes and pharmaceutical compositions containing pemetrexed complexes | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
| WO2011093818A3 (en) | Pharmaceutical compositions comprising salmeterol and fluticasone | |
| HK1221412A1 (zh) | 囊泡 | |
| WO2014007549A3 (ko) | 에스-알릴-엘-시스테인을 유효성분으로 포함하는 대장염 예방 또는 치료용 조성물 및 이를 포함하는 의약제제 |